Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Figure 1. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Figure 1 or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

DDx Deep Dive: Special Episode on Melanoma With Omid Hamid, MD

20:17
 
Share
 

Manage episode 519322577 series 2394692
Content provided by Figure 1. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Figure 1 or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
“All clear” isn’t always the end. Melanoma’s ability to recur months or years after surgery is shifting how clinicians think about treatment timelines. DDx host Raj Bhardwaj, MD, and Omid Hamid, MD, chief of translational research and immunotherapy at The Angeles Clinic and Research Institute in Los Angeles, explore strategies for identifying patients at high risk for melanoma recurrence, new therapeutic approaches before and after surgery, and what these developments mean for the future of melanoma care.
  continue reading

85 episodes

Artwork
iconShare
 
Manage episode 519322577 series 2394692
Content provided by Figure 1. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Figure 1 or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
“All clear” isn’t always the end. Melanoma’s ability to recur months or years after surgery is shifting how clinicians think about treatment timelines. DDx host Raj Bhardwaj, MD, and Omid Hamid, MD, chief of translational research and immunotherapy at The Angeles Clinic and Research Institute in Los Angeles, explore strategies for identifying patients at high risk for melanoma recurrence, new therapeutic approaches before and after surgery, and what these developments mean for the future of melanoma care.
  continue reading

85 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play